London · Delayed Price · Currency is GBP · Price in GBX Ilika Earnings Call Transcripts
Fiscal Year 2026
-
Stereax achieved first commercial deliveries and began generating revenue, while Goliath shipped 10Ah prototypes and opened licensing discussions. Turnover declined to £0.6M due to grant timing, but cash remains strong. Key 2026 milestones include Stereax integration and Goliath customer feedback.
Fiscal Year 2025
-
Solid-state battery developer reported FY revenue of GBP 1.1 million, down year-on-year due to grant timing, but expects Stereax production and revenue in 2025 and strong Goliath prototype validation. Cash reserves exceed GBP 11 million after a successful fundraise.
-
Solid-state battery developer advances Stereax and Goliath product lines, with Stereax entering commercial production via Cirtec and Goliath achieving key prototype milestones. A GBP 3.5 million capital raise will support commercialization, with strong industry partnerships and a robust patent portfolio.
-
Stereax production is set to begin in 2025 with initial revenues expected mid-year, while Goliath batteries advance through key technical milestones and licensing discussions. Cash burn is well managed, and grant funding continues to support scale-up, but revenue growth depends on successful commercialization and customer adoption.
Fiscal Year 2024
-
Asset-light licensing model drives growth in solid-state battery tech for medical and EV markets, with revenue up 200% year-over-year and cost reductions extending cash runway. Stereax commercialization set for 2025, while Goliath advances toward licensing and royalty revenue.